Leaflet DAFIRO 5mg / 80mg film-coated tablets

Indicated for: hypertension

Route of administration: oral

Substance: valsartan + amlodipine (angiotensin II receptor blocker + calcium channel blocker)

ATC: C09DB01 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers)

Precautions:
Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

The combination of valsartan and amlodipine is used for the treatment of hypertension, particularly in patients who require combination therapy to achieve adequate blood pressure control. Valsartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and lowers blood pressure by blocking the effects of angiotensin II. Amlodipine is a calcium channel blocker that helps relax the muscles in the walls of blood vessels, improving blood flow.

This combination is administered orally, usually once daily, and the dosage is adjusted based on the patient's response and blood pressure levels. It is important for patients to adhere to the treatment and regularly monitor their blood pressure.

Common side effects include dizziness, peripheral edema, headaches, and fatigue. In rare cases, severe adverse reactions such as severe hypotension, heart failure, or allergic reactions may occur.

The combination of valsartan and amlodipine provides an effective option for managing hypertension, helping to reduce the risk of cardiovascular complications such as myocardial infarction or stroke.

General data about DAFIRO 5mg / 80mg

  • Substance: valsartan + amlodipine
  • Date of latest medicines list: 01-07-2013
  • Product code: W51854001
  • Concentration: 5mg / 80mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 7
  • Product type: Original
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Concentrations available for valsartan + amlodipine

  • 10mg/160mg
  • 5mg/160mg
  • 5mg/80mg